CSI Market
Sign In | Register

Enzo Biochem Inc (ENZ) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ENZ Annual Cash Flow →
The table below presents a historical view of Enzo Biochem Inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Apr 30 2025)
9 Months 		(Jan 31 2025) (Oct 31 2024) (Jul 31 2024) (Apr 30 2024)
Operating Activities
Income-14.39
Depreciation & amortization0.96
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-1.06
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.52
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.21
Accrual For Share Based401k Employer Match Expense-
Share Based401k Employer Match Expense-
Deferred Revenue Revenue Recognized-
Accrual For Sharebased401k Employer Match Expense-
Sharebased401k Employer Match Expense-
Fair Value Option Changes In Fair Value Gain Loss-
Marketable Securities Unrealized Gain Loss-
Change In Fair Value Of Convertible Debenture-
Gain Loss On Termination Of Lease-
Income taxes0.00
Gain on Sale of Investments0.00
Increase (Decrease) in Accounts Receivable0.38
Increase (Decrease) in Accounts Payable, Trade-0.06
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-9.24
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.73
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net-6.54
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations7.39
Net Cash flow from Operating Activities-14.24
Investing Activities
Capital Expenditures-0.90
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Increase Decrease In Security Deposits And Other-
Security Deposits And Other-
Payments To Earnout-
Increase In Security Deposits And Other-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Proceeds from Other Deposits5.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities4.10
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.08
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-0.16
Other net0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents52.37
Repayments Under Mortgage Agreement And Finance Leases-
Repayments Under Mortgage Agreement Finance Leases And Other-
Cash Payments For Taxes Related To Net Share Settlements Of Equity Awards-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-5.32
Net Cash Flow from Financing Activities-5.57
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-15.14
Total Cash Flow-15.68
4 historic quarters locked

Sign in to unlock the full Enzo Biochem Inc cash flow history.

Sign In Create Free Account

About Enzo Biochem Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-25-054828

Figures are derived from filed reports and may be restated. Historical data is subject to revision.